7DAC | pdb_00007dac

Human RIPK3 amyloid fibril revealed by solid-state NMR

SOLID-STATE NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D DARR 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
15	2D DARR 200ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
16	2D DARR 500ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
2	2D NcaCX 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
3	2D NcoCX 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
4	3D NCACX 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
5	3D NCOCX 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
17	zTEDOR 6.4ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
19	zTEDOR 8.5ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
18	2D RFDR 10.7ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
20	2D INEPT-TOBSY	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
6	2D DARR 50ms mixing	5 mg/mL [U-100% 2-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
7	2D DARR 200ms mixing	5 mg/mL [U-100% 2-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
8	2D DARR 500ms mixing	5 mg/mL [U-100% 2-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
21	zTEDOR 6.4ms mixing	5 mg/mL [U-100% 2-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
22	zTEDOR 8.5ms mixing	5 mg/mL [U-100% 2-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
37	2D NcaCX 50ms mixing	5 mg/mL [U-100% 2-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
38	2D NcoCX 50ms mixing	5 mg/mL [U-100% 2-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
9	2D DARR 50ms mixing	5 mg/mL [U-100% 1, 3-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
10	2D DARR 200ms mixing	5 mg/mL [U-100% 1, 3-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
11	2D DARR 500ms mixing	5 mg/mL [U-100% 1, 3-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
24	zTEDOR 6.4ms mixing	5 mg/mL [U-100% 1, 3-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
26	zTEDOR 8.5ms mixing	5 mg/mL [U-100% 1, 3-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
39	2D NcaCX 50ms mixing	5 mg/mL [U-100% 1, 3-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
40	2D NcoCX 50ms mixing	5 mg/mL [U-100% 1, 3-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
12	2D DARR 50ms mixing	5 mg/mL [U-50% 13C; natural abundance N][natural abandance 13C; U-50% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
13	2D DARR 200ms mixing	5 mg/mL [U-50% 13C; natural abundance N][natural abandance 13C; U-50% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
14	2D DARR 500ms mixing	5 mg/mL [U-50% 13C; natural abundance N][natural abandance 13C; U-50% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
27	zTEDOR 6.4ms mixing	5 mg/mL [U-50% 13C; natural abundance N][natural abandance 13C; U-50% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
28	zTEDOR 8.5ms mixing	5 mg/mL [U-50% 13C; natural abundance N][natural abandance 13C; U-50% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
29	2D NHHC	5 mg/mL [U-50% 13C; natural abundance N][natural abandance 13C; U-50% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
30	2D DARR 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Agilent Direct Drive 700
31	2D DARR 200ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Agilent Direct Drive 700
32	2D DARR 500ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Agilent Direct Drive 700
33	2D NcaCX 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Agilent Direct Drive 700
34	2D NcoCX 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Agilent Direct Drive 700
35	3D NCACX 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Agilent Direct Drive 700
36	3D NCOCX 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Agilent Direct Drive 700

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE NEO	700
2	Agilent	Direct Drive	700

NMR Refinement
Method	Details	Software
simulated annealing		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	96
Conformers Submitted Total Number	12
Representative Model	1 (medoid)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CNS		Brunger A. T. et.al.
2	structure calculation	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore
3	chemical shift assignment	Sparky		Goddard
4	peak picking	Sparky		Goddard